6 Results for "

human S1P1

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "human S1P1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-19511
CAS No.: 1034688-30-6
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4. GSK2018682 is used in the research of multiple sclerosis.
loading...
    loading...
Cat. No.: HY-18166
CAS No.: 1233332-14-3
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

NIBR-0213 is a potent, orally active and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis. NIBR-0213 displays potent and comparable potency on human and rat S1P1 (IC50 of 2.0 nM and 2.3 nM, respectively) in GTPγ 35S assays .
loading...
    loading...
Cat. No.: HY-108493
CAS No.: 913827-99-3
Purity:  99.12%
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

CS-2100 (Compound 10b) is a potent, selective, orally active and S1P3-sparing S1P1 agonist with an EC50 of 4.0 nM for human S1P1. CS-2100 shows in vivo immunosuppressive efficacy in rats with an ID50 (infective dose) of 0.407 mg/kg for HvGR .
loading...
    loading...
Cat. No.: HY-145362
CAS No.: 1883345-11-6
Target:  

LPL Receptor

Research Areas:  

Others

S1P1 agonist 4 has a better profile in both potency (EC50 < 0.05 mg/kg) and predicted human half-life (t1/2 ∼ 5 days).
loading...
    loading...
Cat. No.: HY-14977
CAS No.: 840523-39-9
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

CS-0777-P, the phosphorylated form of CS-0777, acts as a potent and selective modulator of the S1P receptor-1 (S1P1). It exhibits approximately 320-fold higher agonist activity for human S1P1 compared to S1P3, with an EC50 of 1.1 nM. In pharmacological studies, CS-0777-P demonstrated significant effects in vitro as an S1P1 and S1P3 agonist, leading to lowered peripheral blood lymphocyte counts and suppressive effects on experimental autoimmune encephalomyelitis (EAE) in rats. Pharmacokinetic studies in rats revealed rapid lymphocyte count reductions following oral administration, making CS-0777 a promising candidate currently undergoing clinical trials for the treatment of multiple sclerosis (MS) .
loading...
    loading...
Cat. No.: HY-19511A
CAS No.: 1034687-52-9
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

GSK2018682 hydrochloride is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4. GSK2018682 hydrochloride is used in the research of multiple sclerosis.
loading...
    loading...